TB-500

Here's the full product page:

Your body already contains the blueprint for recovery. TB-500 executes it.

Thymosin Beta-4 is a protein found in virtually every cell of the human body. It sits at the centre of how cells move, how wounds close, how blood vessels form, and how tissue rebuilds itself after damage. TB-500 is the synthetic peptide built from its most biologically active region — delivering those repair signals directly, at the site and scale where recovery demands them most.

Outside official research settings, TB-500 has drawn significant attention in sports medicine and orthopaedic settings, where clinicians describe faster recovery from tendon injuries, muscle strains, and chronic soft tissue problems that have not responded to standard care. PubMed

Why TB-500 is the recovery peptide that BPC-157 stacks with — not competes with

BPC-157 initiates the repair signal. TB-500 mobilises the cellular workforce that carries it out. Where BPC-157 targets angiogenic and gut-focused pathways, TB-500 works through actin regulation — the mechanism that physically moves repair cells to where they're needed and organises collagen into functional tissue rather than scar.

Together they cover the full recovery cascade. Alone, TB-500 is one of the most mechanistically complete tissue repair compounds in the peptide space.

Tissue repair that goes deeper than the surface

In rodent models of skeletal muscle injury, TB-500 administration was associated with accelerated muscle fibre regeneration, increased satellite cell proliferation, and reduced fibrotic scarring in recovered tissue. In Achilles tendon injury models, subjects treated with TB-500 showed statistically significant improvements in tendon strength and collagen organisation compared to controls — with the peptide's influence on type I collagen remodelling considered a key mechanism underlying these findings. KlearmindclinicsKlearmindclinics

The result isn't just faster recovery — it's structurally better recovery. Less scar tissue. More functional tissue. A body that comes back stronger rather than just patched.

Inflammation that resolves, not just suppresses

TB-500 research has consistently shown inhibition of inflammatory cytokine production — including TNF-α, IL-1β, and IL-6 — alongside reduced neutrophil migration into injury sites, potentially limiting secondary tissue damage, and modulation of macrophage polarisation toward a pro-repair M2 phenotype. Peptpedia

This distinction matters. TB-500 doesn't switch off inflammation — it guides it toward resolution and repair. The inflammatory phase ends on schedule, and the repair phase begins with the right cellular environment already in place.

Athletic performance and recovery longevity

A 2017 study published in the Journal of Investigative Dermatology showed that thymosin beta-4 peptides accelerated wound healing in animal models by enhancing keratinocyte migration and reducing inflammation. For athletes, this translates directly — faster tissue turnover between sessions, fewer chronic issues accumulating over a career, and a body that keeps pace with training demands rather than gradually falling behind them. PubMed

Clinicians using TB-500 off-label describe consistently faster recovery from tendon injuries, muscle strains, and chronic soft tissue problems that have not responded to standard care — making it particularly valuable for anyone whose recovery has plateaued despite conventional rehabilitation. PubMed

The research behind it

Studies have shown accelerated closure of skin wounds, improved recovery after corneal injury, and faster repair of cardiac tissue after simulated injury. A phase 2 randomised, double-masked clinical trial evaluating thymosin beta-4 in severe dry eye disease demonstrated both safety and meaningful clinical improvement — with a 35% reduction in ocular discomfort and a 59% reduction in corneal staining compared to placebo at day 56. PubMedThepeptidecatalog

The human clinical data is strongest in wound healing and corneal repair, while the musculoskeletal research base — though predominantly preclinical — is among the most consistent and mechanistically well-supported of any recovery peptide available.

Ready to use. No mixing. No guesswork.

Supplied as a pre-mixed pen, TB-500 delivers precise, structured dosing with no reconstitution required — every unit identical, every dose ready from day one.

Dosage Guide

Cycle guidance: Loading phase of 4 weeks followed by a maintenance phase of 4–8 weeks. Acute injuries may benefit from a sustained loading phase until functional recovery is achieved.

Pairs with BPC-157 for a complete soft-tissue recovery stack covering complementary repair pathways.